The Sackler family and Purdue Pharma reached a $7.4 billion settlement with attorneys general from 15 states on Thursday, Jan. 23. The Sacklers have owned the company headquartered in Stamford ...

The Sackler family owned and operated Purdue Pharma, LLP, which manufactured OxyContin and advertised the drug as being less addictive. The drug’s effects and use has been far-reaching because ...

Potentially $57 million, according to a proposed settlement agreement with the family that once owned Purdue Pharma and has been sued by several states to account for its role in the opioid crisis.

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis, ...

If approved, Purdue Pharma will contribute $900 million upfront while the Sackler family pays $6.5 billion over the next 15 years – a $500 million increase from the previous settlement.

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits ...

Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to email a link to a friend (Opens in new window) Click to share on LinkedIn (Opens in new window ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.